JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 125 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $836,420 | +69.4% | 452,119 | +1.7% | 0.00% | – |
Q4 2022 | $493,639 | -58.4% | 444,720 | -12.4% | 0.00% | -100.0% |
Q3 2022 | $1,187,000 | +356.5% | 507,406 | +491.8% | 0.00% | – |
Q2 2022 | $260,000 | -52.6% | 85,735 | +6.0% | 0.00% | – |
Q1 2022 | $549,000 | +30.1% | 80,857 | +59.8% | 0.00% | – |
Q4 2021 | $422,000 | +199.3% | 50,592 | +166.9% | 0.00% | – |
Q3 2021 | $141,000 | +6.0% | 18,957 | -3.1% | 0.00% | – |
Q2 2021 | $133,000 | +15.7% | 19,571 | +74.5% | 0.00% | – |
Q1 2021 | $115,000 | +33.7% | 11,216 | -8.5% | 0.00% | – |
Q4 2020 | $86,000 | +19.4% | 12,257 | +39.6% | 0.00% | – |
Q3 2020 | $72,000 | +30.9% | 8,782 | +10.6% | 0.00% | – |
Q2 2020 | $55,000 | +71.9% | 7,943 | +18.7% | 0.00% | – |
Q1 2020 | $32,000 | -90.8% | 6,691 | -83.3% | 0.00% | – |
Q4 2019 | $348,000 | +25.6% | 40,070 | -52.0% | 0.00% | – |
Q3 2019 | $277,000 | -51.3% | 83,562 | -27.4% | 0.00% | – |
Q2 2019 | $569,000 | -43.6% | 115,151 | -29.3% | 0.00% | -100.0% |
Q1 2019 | $1,008,000 | +99.2% | 162,852 | +8.4% | 0.00% | – |
Q4 2018 | $506,000 | -63.1% | 150,295 | -28.8% | 0.00% | – |
Q3 2018 | $1,372,000 | +128.7% | 211,191 | +169.6% | 0.00% | – |
Q2 2018 | $600,000 | +2.6% | 78,323 | +198.5% | 0.00% | – |
Q1 2018 | $585,000 | +40.6% | 26,236 | -19.7% | 0.00% | – |
Q4 2017 | $416,000 | +28.8% | 32,676 | +56.6% | 0.00% | – |
Q3 2017 | $323,000 | +70.9% | 20,871 | +53.0% | 0.00% | – |
Q2 2017 | $189,000 | +6.8% | 13,638 | +68.5% | 0.00% | – |
Q1 2017 | $177,000 | – | 8,096 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |